Green Cross Corporation (006280)

Overview

GC Biopharma Corp. is a prominent biopharmaceutical entity engaged in the innovation, development, and international distribution of pharmaceutical medicine. Founded in 1967 and headquartered in Yongin-Si, South Korea, the company has etched a global footprint, including a vast array of over-the-counter medications, treatments for various diseases, and vaccines. As a subsidiary of Green Cross Holdings Corporation, it has consolidated its reputation by offering a comprehensive suite of therapeutic solutions, underscoring its commitment to improving healthcare standards worldwide.

Products and Services

Acustop Cataplasma: An over-the-counter offering designed for analgesic and anti-inflammatory purposes, providing relief from pain and inflammation.

Kenhancer plaster: Targeted for anti-inflammatory effects, this product helps in reducing inflammation.

Zenol Cool Type and Zenol Mild Hot Type: Drugs formulated for anti-inflammatory purposes and pain relief, catering to varying patient preferences and conditions.

Albumin-GCC injection (inj.): Administered for conditions like hypoalbuminemia and shock due to acute hemorrhage, as well as in cases of low albumin synthesis.

Antithrombin-III (AT-III) inj.: Used in the treatment of hereditary antithrombin-III deficiency, a critical condition affecting the blood's ability to clot.

Facnyne inj.: A specialized formula for addressing hemophilia B, aiding in the management of this genetic bleeding disorder.

Fibrinogen: Offered for the treatment of hypofibrinogenemia and afibrinogenemia, focusing on conditions where fibrinogen levels in the blood are low.

Gamma Globulin: Essential for addressing hypogammaglobulinemia and agammaglobulinemia, diseases marked by an abnormally low presence of antibodies.

GCFLU Quadrivalent and GC FLU pre-filled syringe inj.: Vaccines formulated for the prevention of influenza, highlighting the company's role in infectious disease control.

GreenGene F inj.: A hemostatic agent for persons with hemophilia A, aimed at controlling bleeding symptoms.

GreenGene inj.: Another product for hemophilia A, focusing on treating bleeding episodes induced by the condition.

Greenplast Q: Designed for sealing tissues and closing wounds, facilitating the body's natural healing process.

Green-VIII inj.: Provides Hemophilia A patients with blood coagulation factor VIII, critical for blood clotting.

Hepabig inj.: Administered for hepatitis B, a liver infection caused by the hepatitis B virus (HBV).

Histobulin: Used in treating bronchial asthma, offering relief from chronic inflammatory disease of the airways.

Hunterase: A treatment for Hunter syndrome, a rare genetic disorder that affects the body's ability to break down certain sugars.

I.V. Hepabig inj.: Aimed at preventing the recurrence of hepatitis B in patients following liver transplantation.

I.V.-Globulin SN inj. 5%: Provides immune system support, crucial for fighting off infections.

Immuncell-LC: A treatment designed to address liver cancer, showcasing the company's commitment to oncological healthcare solutions.

Sero-Tet inj.: Used for the prophylaxis of tetanus and the reduction of tetanus symptoms, further emphasizing GC Biopharma's role in preventive healthcare.

Shinbaro: An agent for anti-inflammation and pain relief, specifically targeting osteoarthritis, a common form of arthritis.

Varicella Vaccine-GCC inj.: A vaccine for the prophylaxis of varicella, also known as chickenpox, a highly contagious viral infection.

Varicella-Zoster Immune Globulin-GCC inj.: Offers passive immunity to susceptible immunodeficient children exposed to varicella, preventing the development of the disease.